Bullish Case: Salesforce's $47.50 all-cash offer anchors BRZE near $45.88 with a defined path to +3.5%. Helium's density puts peak probability exactly at $45.00–47.50 (0.246 density at 45), the 12/18/26 47.5C is the highest-volume contract (8,571 contracts) signaling merger-arb accumulation, and deal close into Salesforce FY2028 offers carry plus upside if bid pressure emerges.

Bearish Case: The 58.1% premium drew analyst skepticism ('a bit odd'), Salesforce shares fell on cost concerns, and closing is deferred to FY2028 — nearly 15 months of regulatory/financing risk. Market IV ticks up through December (12.88→13.81%) and OTM puts retain rich IV (42.5P at 19.5%), showing hedgers still pay for downside protection against a deal break.

Potential Outcomes:

1. ~70% Deal completes on schedule; BRZE converges to $47.50. Falsifiable if spread widens past $2.50 or regulators issue second requests.
2. ~12% Delay/renegotiation on antitrust or financing; price grinds to $41–44. Falsifiable via extended HSR review headlines.
3. ~10% Deal breaks; $300M termination fee cushions only partially — price gaps to ~$28–32 (Helium density shows residual mass at 27.5–30).
4. ~8% Interloper bid or Salesforce raises; pop above $48–50.

October 24, 2026